Effects of denosumab on rheumatic diseases and refractory glucocorticoid-induced osteoporosis: a prospective study

ConclusionsIn conclusion, denosumab is a potential treatment for GIOP in rheumatic diseases, especially in patients refractory to previous therapy, including bisphosphonate therapy.

Source: Archives of Orthopaedic and Trauma Surgery - February 23, 2021 Category: Orthopaedics Source Type: research